Context Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEXTECH INVEST, LTD. | 08/14/2026 | 7.42 M | $4.11 M | 0.00% | 7.79% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 7.42 M | $4.11 M | 0.00% | 7.79% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 7.06 M | $3.91 M | 1.44% | 7.42% |
| BLACKROCK, INC. | 08/07/2026 | 6.17 M | $3.42 M | 628.63% | 6.48% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 5.00 M | $2.77 M | 0.00% | 5.25% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 3.80 M | $2.11 M | 0.00% | 4.00% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.43 M | $1.90 M | 0.00% | 3.61% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2026 | 3.05 M | $1.69 M | -41.90% | 3.20% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 2.93 M | $1.63 M | -42.35% | 3.08% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 2.68 M | $1.49 M | 0.00% | 2.82% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.83 M | $1.01 M | 203.15% | 1.92% |
| STATE STREET CORP | 09/22/2026 | 1.41 M | $782.90 K | 505.30% | 1.48% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 1.30 M | $719.54 K | -87.84% | 1.36% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.04 M | $576.83 K | 469.07% | 1.09% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 1.01 M | $559.00 K | 100.00% | 1.06% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 750.97 K | $415.96 K | 113.89% | 0.79% |
| JANE STREET GROUP, LLC | 08/14/2026 | 645.21 K | $357.38 K | 47.67% | 0.68% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 638.88 K | $353.94 K | 100.00% | 0.67% |
| NORTHERN TRUST CORP | 08/13/2026 | 615.58 K | $340.97 K | 496.16% | 0.65% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 433.89 K | $240.37 K | 27.11% | 0.46% |
| MARSHALL WACE, LLP | 08/13/2026 | 384.53 K | $211.49 K | -86.96% | 0.40% |
| XTX TOPCO LTD | 08/14/2026 | 294.30 K | $163.01 K | 100.00% | 0.31% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 257.07 K | $142.39 K | 2,155.38% | 0.27% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 227.85 K | $126.21 K | 100.00% | 0.24% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 227.85 K | $126.21 K | 100.00% | 0.24% |
| PATHSTONE HOLDINGS, LLC | 08/13/2026 | 214.88 K | $119.02 K | 94.91% | 0.23% |
| TIMOTHY G. YOUNGQUIST 2020 IRREVOCABLE TRUST | 08/07/2026 | 198.38 K | $109.89 K | 100.00% | 0.21% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 163.53 K | $90.58 K | 100.00% | 0.17% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 159.80 K | $89.00 K | 100.00% | 0.17% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 147.29 K | $81.58 K | -89.66% | 0.15% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/29/2026 | 135.30 K | $74.94 K | 100.00% | 0.14% |
| HIGHTOWER ADVISORS, LLC | 08/05/2026 | 125.85 K | $69.71 K | -0.24% | 0.13% |
| PRIVATE ADVISOR GROUP, LLC | 07/27/2026 | 125.85 K | $69.71 K | 100.00% | 0.13% |
| NUVEEN, LLC | 08/11/2026 | 125.52 K | $69.52 K | 100.00% | 0.13% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 109.36 K | $60.58 K | 100.00% | 0.11% |
| NATIXIS | 08/13/2026 | 97.11 K | $54.63 K | 100.00% | 0.10% |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 08/12/2026 | 92.80 K | $51.40 K | 0.00% | 0.10% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 90.88 K | $49.99 K | 100.00% | 0.10% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 84.98 K | $47.07 K | 100.00% | 0.09% |
| WOODLINE PARTNERS LP | 08/14/2026 | 77.93 K | $43.17 K | -68.84% | 0.08% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 77.54 K | $43.00 K | 100.00% | 0.08% |
| CITIGROUP INC | 08/03/2026 | 70.32 K | $38.95 K | 477.27% | 0.07% |
| RHUMBLINE ADVISERS | 08/12/2026 | 69.84 K | $38.69 K | 100.00% | 0.07% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 61.44 K | $34.03 K | 388.70% | 0.06% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 59.70 K | $33.07 K | -40.30% | 0.06% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 59.00 K | $32.69 K | 100.00% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 53.40 K | $29.53 K | -53.52% | 0.06% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 52.71 K | $29.20 K | 100.00% | 0.06% |
| INVESCO LTD. | 08/14/2026 | 50.62 K | $28.04 K | 100.00% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2026 | 42.90 K | $23.76 K | 100.00% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Context Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 106 institutional investors and hedge funds held shares of Context Therapeutics Inc. The most heavily invested institutionals were:
Deep Track Capital, LP: 7.42 M
Nextech Invest, Ltd.: 7.42 M
Soleus Capital Management, L.P.: 7.06 M
BlackRock, Inc.: 6.17 M
Avidity Partners Management LP: 5 M
FRANKLIN RESOURCES INC: 3.8 M
66.23% of Context Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 75.53 M shares in the last 24 months. This purchase volume represents approximately $219.03 M in transactions.